Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholesterol microembolization and stable renal function with continued anticoagulation.

C G Acker1

  • 1Department of Internal Medicine, Eisenhower Army Medical Center, Fort Gordon, Ga.

Southern Medical Journal
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A trial of thyroxine in acute renal failure.

Kidney international·2000
Same author

Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines.

Archives of internal medicine·1998
Same author

Angioedema induced by the angiotensin II blocker losartan.

The New England journal of medicine·1995
See all related articles

Cholesterol microembolization, a complication of oral anticoagulants, can cause organ infarction. However, high-dose heparin therapy stabilized renal function in a patient with purple toes syndrome, suggesting a potential treatment alternative.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Pharmacology

Background:

  • Cholesterol microembolization is a serious complication of oral anticoagulant therapy.
  • It can lead to infarction in multiple organs and has a high mortality rate.
  • Discontinuing anticoagulation was the standard approach to slow disease progression.

Observation:

  • A patient with a prosthetic heart valve developed purple toes syndrome.
  • This syndrome is a known manifestation of cholesterol microembolization.
  • The patient's renal function was monitored closely.

Findings:

  • Initiation of high-dose subcutaneous heparin therapy was administered.
  • Stable renal function was observed following heparin treatment.
  • This suggests heparin may halt or reverse microembolic progression.

Related Experiment Videos

Implications:

  • High-dose heparin may be a viable alternative treatment for cholesterol microembolization.
  • This approach could potentially prevent further organ damage in affected patients.
  • Further research is warranted to confirm the efficacy and safety of heparin in this context.